Hesham El Ghazaly: Congrats Giuseppe Curigliano , joining as ESMO President-Elect 2025-2026
Giuseppe Curigliano shared a post by
“Thank you professor to you personally and to all the community of Egyptian Onco-Hemathologists!”
Quoting
“Congrats Dear Friend Giuseppe Curigliano , joining the ESMO Executive Board on 1 January 2025 as President-Elect 2025-2026, ESMO President 2027-2028, and ESMO Past-President 2029-2030.
Elected ESMO President, well deserved achievement to a dedicated great scientist who has been always determined to make significant strides in improving cancer care globally , willing to see your distinguished impact, to further collaboration across boundaries especially in our countries in Middle East and Africa and the continued success of ESMO’s Initiatives .”
Source: Giuseppe Curigliano/LinkedIn and
Giuseppe Curigliano, MD, PhD, is the Director of the Early Drug Development Division and co-chairs the Experimental Therapeutics Program at the European Institute of Oncology. He is a member of the Department of Oncology and Hemato-Oncology’s steering committee at the University of Milan and serves on the Italian National Health Council, advising the Ministry of Health on cancer policy issues.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023